LC-MS/MS comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-10-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
| Property | Value | Notes |
|---|---|---|
| Reported sequence | Ac-LKKTETQ | Described in most listings as the actin-binding region of thymosin beta-4 |
| Reported molecular weight | Approximately 889 Da | Value shifts with the stated sequence; compare against the certificate of analysis |
| Parent protein length | 43 amino acids | Thymosin beta-4; the fragment covers only a small part of it |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Trade-style names rather than formal nomenclature |
| Formal monographs | Not established | Labeling conventions differ by supplier and region |
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Baptized Sikhs are specifically instructed to have unshorn Kesh (the hair on their head and beards for men) as a major tenet of the Sikh faith. To Sikhs, the maintenance and management of long hair is a manifestation of one's piety. The majority of Muslims believe that adult removal of pubic and axillary hair, as a hygienic measure, is religiously beneficial. Under Muslim law (Sharia), it is recommended to keep the beard. A Muslim may trim or cut hair on the head. In the 9th century, the use of chemical depilatories for women was introduced by Ziryab in Al-Andalus.
An improvement on the loose-coupled train is the "Instanter" coupling, in which the middle link of a three-link chain is specially triangular shaped, so that when lying "prone" it provides enough slack to make coupling possible, but when the middle link is rotated 90 degrees, the length of the chain is effectively shortened, reducing the amount of slack without the need to wind a screw. The closeness of the coupling allows the use of inter-vehicle pipes for train brakes. Three-link and Instanter couplings can be operated entirely from the side of the wagons, using a shunter's pole, which has a hook on the end, and is safer when shunting is being done. Similarly, the screw-adjustable coupler can be connected by a shunter's pole once it has been unscrewed. Ordinary three-link couplings have been superseded by instanter, screw or buck-eye couplers in UK freight trains today.
=== Ion implantation === Accelerating carbon ions inside an electrical field into a semiconductor made of thin nickel films on a substrate of SiO2/Si, creates a wafer-scale (4 inches (100 mm)) wrinkle/tear/residue-free graphene layer at a relatively low temperature of 500 °C.
Sources: en.wikipedia.org
=== Japan === Between 1992 and 1997, Japan's Ministry of International Trade and Industry sponsored a "New Hydrogen Energy (NHE)" program of US$20 million to research cold fusion. Announcing the end of the program in 1997, the director and one-time proponent of cold fusion research Hideo Ikegami stated "We couldn't achieve what was first claimed in terms of cold fusion. (...) We can't find any reason to propose more money for the coming year or for the future." In 1999 the Japan C-F Research Society was established to promote the independent research into cold fusion that continued in Japan. The society holds annual meetings. Perhaps the most famous Japanese cold fusion researcher was Yoshiaki Arata, from Osaka University, who claimed in a demonstration to produce excess heat when deuterium gas was introduced into a cell containing a mixture of palladium and zirconium oxide, a claim supported by fellow Japanese researcher Akira Kitamura of Kobe University and Michael McKubre at SRI.
=== Marketing === The motion poster of Darbar was released on 7 November 2019. Kamal Haasan, Salman Khan, Mohanlal and Mahesh Babu released the film's posters. The film's trailer was released at a launch event in Mumbai on 16 December, with Rajinikanth, Suniel Shetty and Murugadoss in attendance. To make the film's promotion unique, the filmmakers wrapped a SpiceJet aeroplane with Darbar Rajini livery. The external branding of the aircraft bore an image of Rajinikanth in police uniform. Speaking to The Hindu, R. Kannan, chief operating officer (COO) of Lyca Productions said, "The film will release in 7,000 screens across the world. We are planning to release it in a few islands to reach out to the maximum number of people". He said around ₹70–80 million was being spent on promoting the film, calling the marketing investment "one of the highest in Tamil cinema". Kannan said around 15 brands such as SpiceJet, Cadbury's, BookMyShow and Airtel had marketing deals with the film.
A2LA – The American Association for Laboratory Accreditation provides comprehensive services in laboratory accreditation and laboratory-related training. CDPH – The California Department of Public Health is responsible for the public health of California. Maryland Department of Health – The department supports and improves the health and safety through disease prevention, access to care, quality management, and community engagement. License: Pursuant to the provisions of TITLE 17, subtitle 2, Health-General Article 17-201 et seq., Annotated Code of Maryland
Sources: en.wikipedia.org
==== Season 1 ==== At the beginning of the series, the Roys gather to celebrate Logan's 80th birthday, where it is assumed he will step down as CEO and name Kendall as his successor. However, he shocks his family when he announces he will stay on as CEO and hands them documents naming Marcia as his chief trustee upon his death. Logan suffers a debilitating stroke later that day and is admitted to the hospital, where the rest of his family and inner circle debate how to steward the company while he is incapacitated. Logan soon recovers and announces at a gala event that he will remain CEO, but continues displaying erratic behavior. Kendall plots a vote of no confidence against his father along with Roman and several members of the company's senior management, but it ultimately fails, in part because Logan refuses to leave the room during the vote and instead berates several board members into siding with him, while firing everyone who voted for the motion (including Kendall). Over the following months, Logan remains at odds with his children: Shiv goes to work as a political consultant for presidential candidate Gil Eavis, a Democratic Senator who despises Logan and Waystar, while Kendall - a recovering addict - relapses and derails a family therapy session intended to allay public concerns over the company's stability. At Shiv's wedding, Logan learns that Kendall has plotted a hostile takeover of the company alongside his friend Stewy and Logan's nemesis Sandy Furness.
== More studies and projects == Brain Age: Environmental influences in prenatal life have a major impact on brain aging and age-associated brain disorders. Aging is considered as a major risk factor of most neurogenerative diseases such as Alzheimer's or Parkinson's disease for example. EuroBATS: Studies that uses both genetic and biological approaches. Study of 8,000 identical twins to identify markers of aging. The use of improving the length of the telomeres will be used in this process. Frailomic: Utility of biomarkers to characterize elderly individuals at risk for frailty, its progression to disability outcomes, and overall health and well-being consequences. The main objective is to prevent and detect frailty before suffering from it.
== G == Gabriel ethylenimine method Gabriel synthesis Gabriel–Colman rearrangement, Gabriel isoquinoline synthesis Gallagher–Hollander degradation Gassman indole synthesis Gastaldi synthesis Gattermann aldehyde synthesis Gattermann Koch reaction Gattermann reaction Geminal halide hydrolysis Gewald reaction Gibbs phthalic anhydride process Gilman reagent Glaser coupling Glycol cleavage Goldberg reaction Gomberg–Bachmann reaction Gomberg–Bachmann–Hey reaction Gomberg radical reaction Gould–Jacobs reaction Graebe–Ullmann synthesis Grignard degradation Griesbaum coozonolysis Grignard reaction Grob fragmentation Grubbs' catalyst in Olefin metathesis Grundmann aldehyde synthesis Gryszkiewicz–Trochimowski and McCombie method Guareschi–Thorpe condensation Guerbet reaction Gutknecht pyrazine synthesis
Corneal opacification is a term used when the cornea of the eye loses its transparency. The term corneal opacity is used particularly for the loss of transparency of cornea due to scarring. Transparency of the cornea is dependent on the uniform diameter and the regular spacing and arrangement of the collagen fibrils within the stroma. Alterations in the spacing of collagen fibrils in a variety of conditions including corneal edema, scars, and macular corneal dystrophy is clinically manifested as corneal opacity. The term corneal blindness is commonly used to describe blindness due to corneal opacity. Keratoplasty also known as corneal transplantation is the main treatment option for visual improvement in corneal opacity. Other treatments which may improve visual outcome includes optical iridectomy, phototherapeutic keratectomy and keratoprosthesises. Corneal tattooing may be used for improving the cosmetic appearance of the opaque eye.
Sources: en.wikipedia.org
Most listings describe it as a short acetylated peptide with the sequence Ac-LKKTETQ, presented as a region of thymosin beta-4. The label is a trade-style name rather than a standardized chemical name, so the exact content of a given vial depends on the supplier.
No. Thymosin beta-4 is a protein of 43 amino acids, while TB-500 is described as a short fragment of it. The two differ in size, structure, and the range of interactions each can support.
Naming for research peptides is not centrally coordinated, so vendors set their own labels and specifications. Differences in stated sequence, molecular weight, or purity documentation usually trace back to those independent labeling choices.
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.